Literature DB >> 8454614

The structure and mechanism of formation of human calcitonin fibrils.

T Arvinte1, A Cudd, A F Drake.   

Abstract

Turbidity measurements of the kinetics of human calcitonin (hCT) fibrillation showed a linear dependence of the logarithm of fibrillation time (the time the sample is not fibrillated) and the logarithm of hCT concentration. This ln/ln plot linearity and electron microscope observations of fibrils indicate that the fibrillation process can be explained by the double nucleation mechanism that was proposed for the gelation of sickle cell hemoglobin (Ferrone, F. A., Hofrichter, J., Sunshine, H. R., and Eaton, W. A. (1980) Biophys. J. 32, 361-380). Circular dichroism, fluorescence, and infrared spectroscopy studies of fibrils showed that hCT molecules have alpha-helical and beta-sheet secondary structure components. A model for the structure of hCT molecules in fibrils is proposed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454614

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB.

Authors:  M Gross; D K Wilkins; M C Pitkeathly; E W Chung; C Higham; A Clark; C M Dobson
Journal:  Protein Sci       Date:  1999-06       Impact factor: 6.725

2.  Protein engineering as a strategy to avoid formation of amyloid fibrils.

Authors:  V Villegas; J Zurdo; V V Filimonov; F X Avilés; C M Dobson; L Serrano
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

3.  The stability and dynamics of the human calcitonin amyloid peptide DFNKF.

Authors:  Hui-Hsu Tsai; David Zanuy; Nurit Haspel; Kannan Gunasekaran; Buyong Ma; Chung-Jung Tsai; Ruth Nussinov
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

4.  Structure of peptide solutions: a light scattering and numerical study.

Authors:  S U Egelhaaf; V Lobaskin; H H Bauer; H P Merkle; P Schurtenberger
Journal:  Eur Phys J E Soft Matter       Date:  2004-02       Impact factor: 1.890

5.  Scientific considerations for generic synthetic salmon calcitonin nasal spray products.

Authors:  Sau L Lee; Lawrence X Yu; Bing Cai; Gibbes R Johnsons; Amy S Rosenberg; Barry W Cherney; Wei Guo; Andre S Raw
Journal:  AAPS J       Date:  2010-10-30       Impact factor: 4.009

6.  Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.

Authors:  Giuseppina Andreotti; Rosa Maria Vitale; Carmit Avidan-Shpalter; Pietro Amodeo; Ehud Gazit; Andrea Motta
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

7.  Temperature and pH-sensitive polymers for human calcitonin delivery.

Authors:  A Serres; M Baudys; S W Kim
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

8.  FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils.

Authors:  Giorgia Zandomeneghi; Mark R H Krebs; Margaret G McCammon; Marcus Fändrich
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

9.  Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: significant role of Asn ladder.

Authors:  Hui-Hsu Gavin Tsai; Meital Reches; Chung-Jung Tsai; Kannan Gunasekaran; Ehud Gazit; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-27       Impact factor: 11.205

10.  Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin.

Authors:  Susan B Fowler; Stephen Poon; Roman Muff; Fabrizio Chiti; Christopher M Dobson; Jesús Zurdo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.